Aristolochic acid, a naturally occurring compound found in plants of the Aristolochiaceae family, has a history marked by its nephrotoxic and carcinogenic effects. While it was historically used in traditional herbal medicine, studies in the late 20th century revealed that its ingestion could lead to severe kidney damage and an increased risk of urothelial cancers. Aristolochic acid exposure has prompted public health measures including warnings, regulatory restrictions, and the removal of certain herbal products from the market. Its toxicological profile has made it a focus of research into drug-induced nephropathy, with monitoring and screening recommended in populations at risk of exposure.
BRAND NAMES
Aristolochic acid does not have any official pharmaceutical brand names because it is not an approved drug. Its “names” appear only in the context of herbal products or plant sources. Common references include:
Aristolochia fangchi – a plant sometimes used in traditional remedies.
Aristolochia clematitis – another Aristolochia species linked to nephrotoxicity.
MECHANISM OF ACTION
Aristolochic acid exerts its toxic effects primarily through DNA adduct formation. After metabolic activation in the body, it binds covalently to DNA in kidney and urothelial cells, causing mutations and disrupting normal cell replication. These DNA adducts trigger genotoxicity, leading to cell death, fibrosis, and an increased risk of urothelial cancers. Its nephrotoxicity is largely due to damage to proximal tubular epithelial cells, resulting in aristolochic acid nephropathy (AAN), characterized by progressive interstitial fibrosis and renal failure. Unlike therapeutic drugs, its mechanism of action is purely harmful rather than antiviral or therapeutic.
PHARMACOKINETICS
Absorption
Aristolochic acid is absorbed through the gastrointestinal tract after oral ingestion of herbal products containing Aristolochia species. Even small amounts can enter the bloodstream, where it is transported to organs such as the kidneys and liver. The efficiency of absorption can vary depending on the preparation of the plant material, but any absorbed dose can contribute to its toxic effects.
Distribution
Aristolochic acid is distributed mainly to the kidneys and liver, the organs most affected by its toxicity. Small amounts may reach other tissues, but accumulation in the proximal tubular cells of the kidneys is responsible for its nephrotoxic effects. Its distribution contributes to both kidney damage and the increased risk of urothelial cancers.
Metabolism
Aristolochic acid undergoes metabolic activation primarily in the liver through enzymatic reduction and oxidation. This process converts it into reactive intermediates that form covalent DNA adducts in kidney and urothelial cells. These metabolites are highly genotoxic and are responsible for the nephrotoxic and carcinogenic effects associated with aristolochic acid exposure.
Elimination
Aristolochic acid and its metabolites are eliminated slowly from the body, primarily through the urine. The kidneys are the main route of excretion, which contributes to the accumulation of toxic metabolites in renal tissue. This slow elimination, combined with its DNA-binding activity, underlies the progressive kidney damage and long-term risk of urothelial cancers associated with exposure.
PHARMACODYNAMICS
Aristolochic acid exerts its effects by forming covalent adducts with DNA in target cells, particularly in the kidneys and urinary tract. This interaction causes mutations, disrupts normal cell replication, and triggers cell death and fibrosis. The resulting damage leads to progressive kidney disease, known as aristolochic acid nephropathy, and increases the risk of urothelial cancers. Its pharmacodynamic profile is entirely toxic, as it has no therapeutic benefit and its cellular effects are harmful rather than protective or antiviral.
ADMINISTRATION
Aristolochic acid is not approved for medical use and has no safe or recommended dosage form. Exposure occurs primarily through the ingestion of herbal products containing Aristolochia species. Any administration, even in small amounts, can result in nephrotoxicity and an increased risk of cancer, which is why regulatory agencies worldwide have banned its use in herbal remedies and supplements.
DOSAGE AND STRENGTH
Aristolochic acid has no approved therapeutic dosage or strength because it is a toxic compound. Any amount ingested from herbal products can be harmful, with even small exposures linked to kidney damage and an increased risk of urothelial cancers. Regulatory authorities recommend complete avoidance, and there are no safe or standardized preparations for human use.
DRUG INTERACTIONS
Aristolochic acid can increase kidney damage when taken with other nephrotoxic substances. Drugs that affect liver metabolism may also enhance its toxic effects. All co-exposure should be avoided due to its harmful nature.
FOOD INTERACTIONS
There are no known beneficial food interactions with aristolochic acid. Consuming it through contaminated herbal products can lead to kidney damage and cancer, and certain foods that affect liver metabolism may increase its toxicity. Complete avoidance of contaminated products is recommended.
CONTRAINDICATIONS
Aristolochic acid is contraindicated in all individuals due to its nephrotoxic and carcinogenic properties. It should never be ingested, and products containing Aristolochia species are banned in most countries. Individuals with existing kidney disease or a history of urinary tract cancers are at especially high risk and must avoid any exposure.
SIDE EFFECTS
Exposure to aristolochic acid can cause severe kidney damage, leading to progressive renal failure. Other effects include fibrosis of the kidneys, urinary tract cancers, and genotoxic mutations. Even small amounts can result in long-term health consequences, and symptoms may develop slowly over time.
OVER DOSE
An overdose of Aristolochic acid is extremely dangerous and can cause rapid, often irreversible kidney failure known as Aristolochic acid nephropathy, along with a high risk of developing cancers such as urothelial carcinoma; symptoms may include nausea, vomiting, fatigue, reduced urine output, swelling, and sometimes blood in the urine, but damage can occur silently even at low doses over time, and since there is no specific antidote, immediate medical attention is critical if exposure or overdose is suspected.
TOXICITY
Aristolochic acid is highly toxic and classified as both nephrotoxic and carcinogenic. It causes progressive kidney damage, known as aristolochic acid nephropathy, and significantly increases the risk of urothelial cancers. Toxic effects can occur even at low doses, and exposure is irreversible, making complete avoidance essential.
